NEUROONE MEDICAL TECHNOLOGIES Corp financial data

Symbol
NMTC on Nasdaq
Location
7599 Anagram Dr, Eden Prairie, MN
Fiscal year end
September 30
Latest financial report
10-Q - Q2 2025 - Aug 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 348 % +5.17%
Quick Ratio 119 % +18.4%
Debt-to-equity 108 % +182%
Return On Equity -163 % +40.8%
Return On Assets -78.7 % +60.6%
Operating Margin -85.6 % +72.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 50M shares +62.3%
Common Stock, Shares, Outstanding 49.8M shares +78.9%
Entity Public Float 30.3M USD +22.1%
Common Stock, Value, Issued 49.8K USD +78.9%
Weighted Average Number of Shares Outstanding, Basic 48.6M shares +77.7%
Weighted Average Number of Shares Outstanding, Diluted 48.6M shares +77.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 6.63M USD +69%
Cost of Revenue 2.88M USD +3.05%
Research and Development Expense 4.98M USD -13.1%
Operating Income (Loss) -5.67M USD +53.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -5.34M USD +55.9%
Net Income (Loss) Attributable to Parent -5.34M USD +55.9%
Earnings Per Share, Basic 0 USD/shares +68.8%
Earnings Per Share, Diluted 0 USD/shares +68.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 8.04M USD +396%
Accounts Receivable, after Allowance for Credit Loss, Current 319K USD -42.6%
Inventory, Net 1.9M USD +5.81%
Other Assets, Current 21.3K USD
Assets, Current 10.2M USD +149%
Property, Plant and Equipment, Net 315K USD -33.4%
Operating Lease, Right-of-Use Asset 284K USD +0.63%
Intangible Assets, Net (Excluding Goodwill) 50.5K USD -30.6%
Assets 10.8M USD +120%
Accounts Payable, Current 468K USD -38.4%
Accrued Liabilities, Current 958K USD +2.83%
Liabilities, Current 1.43M USD -15.7%
Long-term Debt and Lease Obligation 55.3K USD -53.8%
Operating Lease, Liability, Noncurrent 175K USD -16.5%
Liabilities 2.64M USD +39%
Retained Earnings (Accumulated Deficit) -77M USD -7.45%
Stockholders' Equity Attributable to Parent 8.18M USD +172%
Liabilities and Equity 10.8M USD +120%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 208K USD
Net Cash Provided by (Used in) Financing Activities -509K USD -142%
Net Cash Provided by (Used in) Investing Activities -24.4K USD +34.2%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 49.8M shares +78.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 8.04M USD +396%
Deferred Tax Assets, Valuation Allowance 19M USD +23.3%
Deferred Tax Assets, Gross 19.2M USD +22.6%
Operating Lease, Liability 296K USD +1.94%
Depreciation 239K USD +7.32%
Payments to Acquire Property, Plant, and Equipment 37.1K USD +223%
Lessee, Operating Lease, Liability, to be Paid 325K USD -2.17%
Property, Plant and Equipment, Gross 1.05M USD +8.35%
Operating Lease, Liability, Current 120K USD +50.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 28.9K USD -30.8%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 284K USD +22.5%
Operating Lease, Payments 35.1K USD +3.09%
Additional Paid in Capital 85.1M USD +14%
Amortization of Intangible Assets 22.3K USD 0%
Share-based Payment Arrangement, Expense 1.25M USD -2.27%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%